MktsMarkets

Envoy Medical, Inc.
NASDAQ: COCHKey statistics
COCH News
Stories mentioning COCH from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 39.00 | 75.00 | 42.00 | 78.00 | 46.00 | 42.00 | 56.00 | 68.00 |
| Cost of Goods Sold | 313.00 | 211.00 | 203.00 | 234.00 | 226.00 | 157.00 | 187.00 | 245.00 |
| Gross Profit | (274.00) | (136.00) | (161.00) | (156.00) | (180.00) | (115.00) | (131.00) | (177.00) |
| Operating Expenses | ||||||||
| Research & Development | 3,642 | 4,553 | 2,700 | 2,485 | 2,748 | 2,471 | 2,757 | 2,591 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (5,959) | (6,385) | (5,708) | (5,070) | (5,107) | (4,548) | (4,972) | (4,852) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 6.00 | (16.00) | 5.00 | (1.00) | (11.00) | (17.00) | 13.00 | (8.00) |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (4,351) | (6,586) | (6,482) | (5,690) | (4,998) | (4,618) | (5,960) | (3,947) |
| Earnings Per Share (Basic) | (0.08) | (0.28) | (0.35) | (0.32) | (0.29) | (0.25) | (0.39) | (0.29) |
| Earnings Per Share (Diluted) | (0.08) | (0.28) | (0.35) | (0.32) | (0.29) | (0.25) | (0.39) | (0.29) |
| Weighted Average Shares Outstanding (Basic) | 68,935 | 23,260 | 21,852 | 21,384 | 21,327 | 18,790 | 18,616 | 18,600 |
| Weighted Average Shares Outstanding (Diluted) | 68,935 | 23,260 | 21,852 | 21,384 | 21,327 | 18,790 | 18,616 | 18,600 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About COCH
Envoy Medical, Inc. (NASDAQ: COCH) is a stock listed on the Nasdaq Stock Market under the ticker symbol COCH. It last traded at $6.50 (Oct 29, 2026, 4:00 PM ET), down 2.4% on the day. That gives Envoy Medical a market capitalisation of $50.3M.
Over the past 52 weeks COCH has traded between $3.62 and $9.54.
Revenue for the quarter ended Mar 31, 2026 was $39.0K; a net loss of $4.4M. Revenue was down 15.2% from $46.0K in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $39.0K | -$4.4M | -11156.4% |
| Dec 31, 2025 | $75.0K | -$6.6M | -8781.3% |
| Sep 30, 2025 | $42.0K | -$6.5M | -15433.3% |
| Jun 30, 2025 | $78.0K | -$5.7M | -7294.9% |
From Envoy Medical’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…